MariMed (MRMD) News Today $0.11 0.00 (-2.09%) As of 01/31/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Avant Brands (OTCMKTS:AVTBF) & MariMed (OTCMKTS:MRMD) Financial ComparisonFebruary 1 at 2:23 AM | americanbankingnews.comMariMed Commences Wholesale Operations in MissouriDecember 23, 2024 | globenewswire.comMariMed (OTCMKTS:MRMD) Shares Up 0.4% - Here's What HappenedMariMed (OTCMKTS:MRMD) Stock Price Up 0.4% - Should You Buy?December 5, 2024 | marketbeat.comVentum Cap Mkts Weighs in on MariMed FY2026 EarningsMariMed Inc. (OTCMKTS:MRMD - Free Report) - Equities researchers at Ventum Cap Mkts issued their FY2026 earnings estimates for shares of MariMed in a research note issued on Thursday, November 7th. Ventum Cap Mkts analyst A. Semple anticipates that the company will earn $0.00 per share for the yeNovember 11, 2024 | marketbeat.comMariMed Reports Third Quarter 2024 EarningsNovember 6, 2024 | globenewswire.comInHouse by MariMed Launches Help on the Homefront, to Support Veterans Facing Housing ChallengesOctober 31, 2024 | globenewswire.comMariMed Commences Manufacturing Operations in MissouriOctober 30, 2024 | globenewswire.comShort Interest in MariMed Inc. (OTCMKTS:MRMD) Increases By 302.2%MariMed Inc. (OTCMKTS:MRMD - Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 125,500 shares, a growth of 302.2% from the September 30th total of 31,200 shares. Based on an average trading volume of 853,800 shares, the days-to-cover ratio is currently 0.1 days.October 26, 2024 | marketbeat.comCan MariMed's $7.7M Illinois Cannabis Expansion Turn The Tide In A $496M Market?October 24, 2024 | benzinga.comCannabis Chart Of The Week: Consensus 2024 EBITDA Estimates Are Still Up 8.4% Despite Downward RevisionsOctober 14, 2024 | benzinga.comMariMed Commences Cultivation Operations in Mt. Vernon, Illinois Grow FacilityOctober 14, 2024 | globenewswire.comShort Interest in MariMed Inc. (OTCMKTS:MRMD) Decreases By 31.9%MariMed Inc. (OTCMKTS:MRMD - Get Free Report) saw a large decline in short interest in September. As of September 30th, there was short interest totalling 31,200 shares, a decline of 31.9% from the September 15th total of 45,800 shares. Based on an average trading volume of 574,500 shares, the days-to-cover ratio is presently 0.1 days.October 12, 2024 | marketbeat.comMariMed Announces Third Quarter 2024 Earnings DateOctober 7, 2024 | globenewswire.comMariMed’s Nature’s Heritage Gives Local Musicians a Chance to be Featured in New Interactive Vape CampaignOctober 1, 2024 | finance.yahoo.comMariMed's Nature's Heritage Gives Local Musicians a Chance to be Featured in New Interactive Vape CampaignOctober 1, 2024 | globenewswire.comMariMed’s Betty’s Eddies Partners With Keep A Breast Foundation to Promote Breast Cancer Screening EducationSeptember 30, 2024 | markets.businessinsider.comMariMed's Betty's Eddies Partners With Keep A Breast Foundation to Promote Breast Cancer Screening EducationSeptember 30, 2024 | globenewswire.comMariMed Commences Adult-Use Sales at Thrive Wellness Dispensary in Tiffin, OhioSeptember 24, 2024 | globenewswire.comMariMed Inc. (OTCMKTS:MRMD) Short Interest UpdateMariMed Inc. (OTCMKTS:MRMD - Get Free Report) saw a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 25,800 shares, a decrease of 49.7% from the August 15th total of 51,300 shares. Based on an average daily trading volume, of 981,100 shares, the days-to-cover ratio is currently 0.0 days.September 13, 2024 | marketbeat.comMariMed’s Bubby’s Baked Introduces New, Limited-Edition Pumpkin Bread Bites This AutumnSeptember 10, 2024 | markets.businessinsider.comKey Cannabis Leaders Gather For Networking At Benzinga's Fall 2024 Conference: The Last Big Event Before The ElectionAugust 26, 2024 | msn.comMariMed Inc. (MRMD.CN)August 23, 2024 | uk.finance.yahoo.comMariMed Announces Opening of Second Maryland DispensaryAugust 19, 2024 | globenewswire.comVerano, Green Thumb & MariMed's Strong Q2: Unpacking The Cannabis Earnings SurgeAugust 16, 2024 | benzinga.comCanadian Securities Exchange (CSE): Canadian Securities Exchange Reports July 2024 Performance FiguresAugust 14, 2024 | finanznachrichten.deCanadian Securities Exchange Reports July 2024 Performance FiguresAugust 14, 2024 | msn.comMariMed succeeds with growth strategy prioritizing conservatism over quick winsAugust 14, 2024 | proactiveinvestors.comCannabis Rescheduling Likely 'In The Next 12 Months,' Says MariMed CEO As Company Invests In Key MarketsAugust 12, 2024 | msn.comMRMD Stock Earnings: MariMed Beats Revenue for Q2 2024August 8, 2024 | markets.businessinsider.comMariMed Reports Second Quarter 2024 EarningsAugust 7, 2024 | globenewswire.comMariMed Announces Appointment of Mario Pinho as Chief Financial OfficerAugust 7, 2024 | globenewswire.comThe King Of Ohio's Recreational Cannabis Market? Here's Why Investors Should Follow This Weed StockAugust 6, 2024 | msn.comMariMed Commences Operations In Newly Expanded Area of Maryland Cultivation FacilityJuly 22, 2024 | globenewswire.comMariMed Announces Second Quarter 2024 Earnings DateJuly 9, 2024 | globenewswire.comMariMed Announces Approval of Adult-Use Sales At Panacea Wellness Dispensary in Quincy, Massachusetts and Updates for Ohio and MarylandJuly 2, 2024 | globenewswire.comMariMed Closes Acquisition of Second Maryland DispensaryJuly 2, 2024 | globenewswire.comMariMed Inc. (OTCMKTS:MRMD) Short Interest Down 95.7% in JuneMariMed Inc. (OTCMKTS:MRMD - Get Free Report) saw a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 1,200 shares, a decrease of 95.7% from the May 31st total of 27,900 shares. Based on an average daily volume of 737,600 shares, the days-to-cover ratio is currently 0.0 days.June 27, 2024 | marketbeat.comCannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock's Market Cap By 170%May 22, 2024 | markets.businessinsider.comAnalysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37MMay 14, 2024 | markets.businessinsider.comCannabis Chart Of The Week: Analysts React Meekly To Strong Q1'24 EarningsMay 13, 2024 | benzinga.comMariMed Inc. (PNK:MRMD) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.comAnalysts Are Bullish on These Healthcare Stocks: MariMed (MRMD), Trevi Therapeutics (TRVI)May 9, 2024 | markets.businessinsider.comMariMed Inc.: MariMed Reports First Quarter 2024 EarningsMay 9, 2024 | finanznachrichten.deMRMD Stock Earnings: MariMed Beats Revenue for Q1 2024May 9, 2024 | msn.comQ1 2024: MariMed's Revenue Rises To $37.9M, Amid Declining Gross MarginMay 9, 2024 | msn.comQ1 2024: MariMed's Revenue Rises To $37.9M, Shrinks Losses While Increasing Wholesale RevenueMay 9, 2024 | markets.businessinsider.comMariMed Reports First Quarter 2024 EarningsMay 8, 2024 | globenewswire.comCannabis Industry Leaders React To DEA's Historic Move To Reschedule CannabisApril 30, 2024 | msn.comStatement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration’s Decision To Recategorize Cannabis To Schedule IIIApril 30, 2024 | finance.yahoo.comStatement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration's Decision To Recategorize Cannabis To Schedule IIIApril 30, 2024 | globenewswire.com Get MariMed News Delivered to You Automatically Sign up to receive the latest news and ratings for MRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address MRMD Media Mentions By Week MRMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRMD News Sentiment▼0.000.69▲Average Medical News Sentiment MRMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRMD Articles This Week▼31▲MRMD Articles Average Week Get MariMed News Delivered to You Automatically Sign up to receive the latest news and ratings for MRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADCT News PLX News VXRT News LYEL News ALEC News NKTX News ZNTL News GLSI News STRO News DRUG News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MRMD) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MariMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MariMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.